- 2016.05
The Transfer of the Headquater of CombiMed to Yanggu-gun in Kangwon Province :
Market Launch of Enzyme & Probiotics ; “ IM Enzyme”
- 2015.4
Finish of the construction of the Fermenting Facility at Kangwon Province
- 2013.
Provision Agreement with Amore Pacific Subsidy Company :
Herb Enzyme & Probiotics
- 2012-2016
Finishing the development of Enzyme & Probiotics for AD.
Has Treated About 1,500 AD patients at Atofine Hospital : cure ratio : 70-80%
- 2011.3
Non-formal Clinical Trials for AD :
with Herb Enzyme & Probiotics Materials , 30 Subjects
- 2009
Development of National Project :
Natural Fermented Materials for AD by balancing the immune system
- 2008
Online Shipping Mall Open : http://atofinemall.com/
- 2008.5
Technology Transfer Agreement with Korea Univ. :
CD8 T Cell for curing effect for AD
- 2007.12
Collaboration Agreement with Korea Univ. :
Cell Therapeutics for Atopy Dermatitis - 2007.5
Establishment of Atopy Dermatology Association ;
300 oriental Doctors enrolled - 2007.1
ECollaboration with Chungbuk Univ. :
Search of the Probiotics ;
1. among 120 probiotics,
2. inhancing Th1, decreasing the cytokine for Th2.
- 2003-2012
Collaboration with Kyunghee Univ. and Korea Univ. :
Search of Th 1 intensifying drug materials ;
1. for 4 years, from the bloods of 500 AD patients, 1,000 cultivation experiments of white blood cell
2. Candidate Materials : 140
3. 33 materials patent apply for Th1 inhancing
- 2002
Incorporation of CombiMed